This article is more than 5 years old. Information may no longer be current.

FDA approves another hyaluronic acid filler

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA BARBARA, Calif. — U.S. regulators have approved a hyaluronic acid-based dermal filler that is indicated for the correction of moderate to severe facial wrinkles and folds, the product’s marketer announced.

Hylaform Plus (hylan-B gel, Inamed) is a clear, colorless gel with a larger mean hyaluronic acid particle size than the previously approved product Hylaform, according to a press release from Inamed.

Inamed Corp. is the exclusive U.S. marketer of the two hyaluronic acid dermal fillers, which are manufactured by Genzyme. Other fillers in Inamed’s line include the collagen products Zyderm, Zyplast, CosmoDerm and CosmoPlast.